as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
4.86%
Downside
1.62%
Upside
52 Week's Low
52 Week's High
74.34%
Downside
129.73%
Upside
Check Matinas Biopharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.0M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.02
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
-12.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
41853100.00%
Track how Matinas Biopharma Holdings Inc P/E has moved over time to understand its valuation trends.
Matinas Biopharma Holdings Inc in the last 5 years
Lowest (0.00x)
September 13, 2025
Industry (0.00x)
September 13, 2025
Today (-1.02x)
September 13, 2025
Highest (-0.18x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.02x
Compare market cap, revenue, PE, and other key metrics of Matinas Biopharma Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $10.0M | -94.72% | -1.02 | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Matinas Biopharma Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Matinas Biopharma Holdings Inc investment value today
Current value as on today
₹53,316
Returns
Returns from Matinas Biopharma Holdings Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Matinas Biopharma Holdings Inc. Average target price of $30
Get share price movements and forecasts by analysts on Matinas Biopharma Holdings Inc.
What analysts predicted
93.83%UPSIDE
Target Price
$30
Current Price
$1.85
Analyzed by
9 Analysts
Target
$30.00
Matinas Biopharma Holdings Inc target price $30, a slight upside of 93.83% compared to current price of $1.85. According to 9 analysts rating.
Investment in Matinas Biopharma Holdings Inc Shares on INDmoney has grown by 546.15% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:546.15% versus previous 30 day period
Search interest for Matinas Biopharma Holdings Inc Stock has increased by 454% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:454% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, MTNB stock has moved up by 20.5%
Revenue Rich
Revenue is up for the last 2 quarters, -1.09M → 962.0K (in $), with an average increase of 213.9% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 126.7%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 220.3%
Profit Down
Netprofit is down for the last 2 quarters, -1.65M → -5.24M (in $), with an average decrease of 216.7% per quarter
Organisation | Matinas Biopharma Holdings Inc |
Headquarters | 1545 Route 206 South, Bedminster, NJ, United States, 07921 |
Industry | Health Technology |
CEO | Mr. Jerome D. Jabbour J.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Jerome D. Jabbour J.D. | Co-Founder, Chairman, CEO and President |
Mr. Keith A. Kucinski CPA, M.B.A. | Chief Financial Officer |
Matinas Biopharma Holdings Inc share price today is $1.85 as on at the close of the market. Matinas Biopharma Holdings Inc share today touched a day high of $1.88 and a low of $1.76.
Matinas Biopharma Holdings Inc share touched a 52 week high of $4.25 on and a 52 week low of $0.47 on . Matinas Biopharma Holdings Inc stock price today i.e. is closed at $1.85,which is 56.47% down from its 52 week high and 289.64% up from its 52 week low.
Matinas Biopharma Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Matinas Biopharma Holdings Inc (MTNB) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Matinas Biopharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Matinas Biopharma Holdings Inc share’s latest price of $1.85 as on September 13, 2025 at 1:29 am IST, you will get 5.4054 shares of Matinas Biopharma Holdings Inc. Learn more about
fractional shares .
Matinas Biopharma Holdings Inc stock has given -94.72% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?